These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37277227)

  • 1. Implementation of pharmacogenetic testing in medication reviews in a hospital setting.
    Hjemås BJ; Bøvre K; Bjerknes K; Mathiesen L; Mellingsaeter MCR; Molden E
    Br J Clin Pharmacol; 2023 Oct; 89(10):3116-3125. PubMed ID: 37277227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of Pharmacogenetic Testing to Modeled Medication Change Recommendations in a Long-Term Care Population with Polypharmacy.
    Sugarman EA; Cullors A; Centeno J; Taylor D
    Drugs Aging; 2016 Dec; 33(12):929-936. PubMed ID: 27826798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
    Ramsey LB; Ong HH; Schildcrout JS; Shi Y; Tang LA; Hicks JK; El Rouby N; Cavallari LH; Tuteja S; Aquilante CL; Beitelshees AL; Lemkin DL; Blake KV; Williams H; Cimino JJ; Davis BH; Limdi NA; Empey PE; Horvat CM; Kao DP; Lipori GP; Rosenman MB; Skaar TC; Teal E; Winterstein AG; Owusu Obeng A; Salyakina D; Gupta A; Gruber J; McCafferty-Fernandez J; Bishop JR; Rivers Z; Benner A; Tamraz B; Long-Boyle J; Peterson JF; Van Driest SL;
    JAMA Netw Open; 2020 Dec; 3(12):e2029411. PubMed ID: 33315113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of a pharmacist-led medication review programme for hospitalised elderly patients.
    Chiu KC; Lee WK; See YW; Chan HW
    Hong Kong Med J; 2018 Apr; 24(2):98-106. PubMed ID: 29302017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users.
    Chanfreau-Coffinier C; Hull LE; Lynch JA; DuVall SL; Damrauer SM; Cunningham FE; Voight BF; Matheny ME; Oslin DW; Icardi MS; Tuteja S
    JAMA Netw Open; 2019 Jun; 2(6):e195345. PubMed ID: 31173123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of drug-related problems at the emergency department in older patients living with frailty: pharmacist-led medication reviews within a geriatric care team.
    van Nuland M; Butterhoff M; Verwijmeren K; Berger F; Hogervorst VM; de Jonghe A; van der Linden PD
    BMC Geriatr; 2023 Apr; 23(1):215. PubMed ID: 37016324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of early in-hospital medication review by clinical pharmacists on health services utilization.
    Hohl CM; Partovi N; Ghement I; Wickham ME; McGrail K; Reddekopp LN; Sobolev B
    PLoS One; 2017; 12(2):e0170495. PubMed ID: 28192477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of preemptive pharmacogenetic testing in colorectal cancer patients within a community oncology setting.
    Luczak TS; Schillo PJ; Renier CM; Waring SC; Friday BB
    J Oncol Pharm Pract; 2022 Jun; 28(4):842-849. PubMed ID: 33853470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting.
    Bousman CA; Jaksa P; Pantelis C
    Pharmacogenet Genomics; 2017 Nov; 27(11):387-393. PubMed ID: 28777243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community pharmacists' experience with pharmacogenetic testing.
    Moaddeb J; Mills R; Haga SB
    J Am Pharm Assoc (2003); 2015; 55(6):587-594. PubMed ID: 26409205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of pharmacogenetic testing in primary care: Attitudes of patients, general practitioners, and pharmacists.
    Hansen JM; Nørgaard JDSV; Kälvemark Sporrong S
    Res Social Adm Pharm; 2022 Aug; 18(8):3230-3238. PubMed ID: 34996718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic testing in pediatric neurology: a pragmatic study evaluating clinician and patient perceptions.
    Pépin MA; Otis AS; Tremblay Z; Boulé M; Lebel D; Major P; Lortie A; Pinchefsky E; Rossignol E; Carleton B; Bussières JF; Métras MÉ
    Per Med; 2022 Sep; 19(5):423-434. PubMed ID: 35830229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-related problems identified by pharmacist-led medication review in Slovak hospitalised patients.
    Kováčová B; ĎuriŽová A
    Pharmazie; 2016 Sep; 71(9):548-551. PubMed ID: 29441854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of pharmacist-led medication reconciliation and interprofessional ward rounds on drug-related problems at hospital discharge.
    Studer H; Imfeld-Isenegger TL; Beeler PE; Ceppi MG; Rosen C; Bodmer M; Boeni F; Hersberger KE; Lampert ML
    Int J Clin Pharm; 2023 Feb; 45(1):117-125. PubMed ID: 36327045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice.
    Russmann S; Rahmany A; Niedrig D; Hatz KD; Ludin K; Burden AM; Englberger L; Backhaus R; Serra A; Béchir M
    Eur J Clin Pharmacol; 2021 May; 77(5):709-716. PubMed ID: 33242107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic testing among patients with depression in a US managed care population.
    Anderson HD; Thant TM; Kao DP; Crooks KR; Mendola ND; Aquilante CL
    Clin Transl Sci; 2022 Jul; 15(7):1644-1653. PubMed ID: 35385214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
    Altavela JL; Jones MK; Ritter M
    J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.
    Haga SB; Mills R; Moaddeb J; Allen LaPointe N; Cho A; Ginsburg GS
    Pharmacogenomics; 2017 Mar; 18(4):359-367. PubMed ID: 28244812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit of medication reviews by renal pharmacists in the setting of a computerized physician order entry system with clinical decision support.
    Seiberth S; Mannell H; Birkenmaier C; Neuerburg C; Smolka V; Andraschko M; Strobach D
    J Clin Pharm Ther; 2022 Oct; 47(10):1531-1538. PubMed ID: 35868964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.